What are the conditions required for administering Ketorolac?

Administering Ketorolac requires specific conditions to ensure patient safety and therapeutic efficacy. The correct choice focuses on the criterion that the patient must be equal to or greater than 12 years old and normotensive.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that can be effective in managing moderate to severe pain, especially in acute settings. Patients who are 12 years or older generally have a higher risk tolerance and are more likely to benefit from NSAIDs. Additionally, a normotensive state indicates that the patient's blood pressure is within a normal range, which is crucial because NSAIDs can affect kidney function and overall hemodynamic stability. Administering Ketorolac to a hypotensive patient could exacerbate potential issues and lead to further complications.

In contrast, being less than 12 years old and unresponsive would raise concerns about the safe use of medication, particularly due to differences in pharmacokinetics and potential adverse effects in younger populations. A history of heart disease is also a concern, as NSAIDs may increase the risk of cardiovascular events. Lastly, recent NSAID use could lead to an increased risk of gastrointestinal bleeding or kidney issues, making it essential to consider the timing of prior medication use.